Company Filing History:
Years Active: 2022
Title: Innovations of Jingfang Zhang
Introduction
Jingfang Zhang is a notable inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific kinases associated with tumor growth and metastasis. With a total of 2 patents, his work is paving the way for new therapeutic options.
Latest Patents
Jingfang Zhang's latest patents include innovative compounds and methods that have potential applications in medicine. One of his patents focuses on substituted penta-fused hexa-heterocyclic compounds, which exhibit selective inhibition for PIKfyve kinase. This invention includes a preparation method, a pharmaceutical composition, and the use of these compounds in the manufacture of medicaments aimed at preventing or treating diseases associated with PIKfyve, particularly in the context of tumor growth and metastasis. Another patent involves a substituted aryl ether compound, detailing its preparation method, pharmaceutical composition, and its use in the manufacture of medicaments for tumor treatment.
Career Highlights
Jingfang Zhang is affiliated with Xiamen University, where he conducts research and develops his innovative ideas. His academic background and research focus have positioned him as a key figure in the pharmaceutical field.
Collaborations
Jingfang Zhang collaborates with esteemed colleagues such as Xianming Deng and Xihuan Sun, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Jingfang Zhang's contributions to pharmaceutical innovations highlight his role as a leading inventor in the field. His patents reflect a commitment to advancing medical science and improving treatment options for patients.